{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:40:16Z","timestamp":1789800016331,"version":"4.0.1"},"reference-count":156,"publisher":"Endocrinology Research Centre","issue":"5","license":[{"start":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p>The precocious puberty is an urgent problem of pediatric endocrinology characterized by clinical and pathogenetic heterogeneity. The appearance of secondary sex characteristics before the age of 8 years in girls and 9 years in boys requires timely diagnosis and the appointment of pathogenetically justified treatment in order to achieve the target indicators of final growth and prevent social deprivation. The developed clinical guidelines are the main working tool of the practitioner. They briefly and structurally present the main information about the epidemiology and modern classification of \u0440recocious puberty, methods of its diagnosis and treatment based on the principles of evidence-based medicine.<\/jats:p>","DOI":"10.14341\/probl12821","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T07:31:07Z","timestamp":1636702267000},"page":"84-103","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":12,"title":["Clinical guidelines \u00abPrecocious puberty\u00bb"],"prefix":"10.14341","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5507-4627","authenticated-orcid":true,"given":"V. A.","family":"Peterkova","sequence":"first","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-1337","authenticated-orcid":true,"given":"I. L.","family":"Alimova","sequence":"additional","affiliation":[{"name":"Smolensk State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7063-1161","authenticated-orcid":true,"given":"E. B.","family":"Bashnina","sequence":"additional","affiliation":[{"name":"North-Western State Medical University named after I.I. Mechnikov"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-5732","authenticated-orcid":true,"given":"O. B.","family":"Bezlepkina","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8148-526X","authenticated-orcid":true,"given":"N. V.","family":"Bolotova","sequence":"additional","affiliation":[{"name":"Saratov State Medical University named after V. I. Razumovsky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6097-7831","authenticated-orcid":true,"given":"N. A.","family":"Zubkova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2000-7694","authenticated-orcid":true,"given":"N. U.","family":"Kalinchenko","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-6561","authenticated-orcid":true,"given":"M. A.","family":"Kareva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-5242","authenticated-orcid":true,"given":"A. V.","family":"Kiyaev","sequence":"additional","affiliation":[{"name":"Ural State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-5372","authenticated-orcid":true,"given":"A. A.","family":"Kolodkina","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0112-3785","authenticated-orcid":true,"given":"I. B.","family":"Kostrova","sequence":"additional","affiliation":[{"name":"N.M. Kuraev Children\u2019s Republican Clinical Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-6367","authenticated-orcid":true,"given":"N. V.","family":"Makazan","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-0867","authenticated-orcid":true,"given":"O. A.","family":"Malievskiy","sequence":"additional","affiliation":[{"name":"Bashkir State Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6196-5322","authenticated-orcid":true,"given":"E. M.","family":"Orlova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-2378","authenticated-orcid":true,"given":"E. E.","family":"Petryaykina","sequence":"additional","affiliation":[{"name":"Russian Children\u2019s Clinical Hospital, Pirogov Russian National Research Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0208-4116","authenticated-orcid":true,"given":"L. N.","family":"Samsonova","sequence":"additional","affiliation":[{"name":"Russian Medical Academy of Continuous Professional Education"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-8001","authenticated-orcid":true,"given":"T. E.","family":"Taranushenko","sequence":"additional","affiliation":[{"name":"Krasnoyarsk State Medical University named after V.F. Voino-Yasenetsky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5458","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"ref1","unstructured":"Dedov II, Semicheva TV, Peterkova VA. Polovoe razvitie: norma i patologiya. Moscow: Kolor It Studio; 2002. P. 67-69. (In Russ.)."},{"key":"ref2","unstructured":"Dedov II, Peterkova VA. Rukovodstvo po detskoi endokrinologii. Moscow: Universum pablishing; 2006. (In Russ.)."},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Carel J-C, Eugster EA, Rogol A, et al. Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. Pediatrics. 2009;123(4):e752-e762. doi: https:\/\/doi.org\/10.1542\/peds.2008-1783","DOI":"10.1542\/peds.2008-1783"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in the Pattern of Pubertal Changes in Boys. Arch Dis Child. 1970;45(239):13-23. doi: https:\/\/doi.org\/10.1136\/adc.45.239.13","DOI":"10.1136\/adc.45.239.13"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chen M, Eugster EA. Central Precocious Puberty: Update on Diagnosis and Treatment. Pediatr Drugs. 2015;17(4):273-281. doi: https:\/\/doi.org\/10.1007\/s40272-015-0130-8","DOI":"10.1007\/s40272-015-0130-8"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Partsch C-J, Japing I, Siebert R, et al. Central precocious puberty in girls with Williams syndrome. J Pediatr. 2002;141(3):441-444. doi: https:\/\/doi.org\/10.1067\/mpd.2002.127280","DOI":"10.1067\/mpd.2002.127280"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Temple IK, Cockwell A, Hassold T, et al. Maternal uniparental disomy for chromosome 14. J Med Genet. 1991;28(8):511-514. doi: https:\/\/doi.org\/10.1136\/jmg.28.8.511","DOI":"10.1136\/jmg.28.8.511"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Ioannides Y, Lokulo-Sodipe K, Mackay DJ, et al. Temple syndrome: improving the recognition of an underdiagnosed chromosome 14 imprinting disorder: an analysis of 51 published cases. J Med Genet. 2014;51(8):495-501. doi: https:\/\/doi.org\/10.1136\/jmedgenet-2014-102396","DOI":"10.1136\/jmedgenet-2014-102396"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Wakeling EL, Brioude F, Lokulo-Sodipe O, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 2017;13(2):105-124. doi: https:\/\/doi.org\/10.1038\/nrendo.2016.138","DOI":"10.1038\/nrendo.2016.138"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Berbero\u011flu M. Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management. J Clin Res Pediatr Endocrinol. 2009;1(4):164-174. doi: https:\/\/doi.org\/10.4274\/jcrpe.v1i4.3","DOI":"10.4274\/jcrpe.v1i4.3"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Haddad NG, Eugster EA. Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes. Best Pract Res Clin Endocrinol Metab. 2019;33(3):101273. doi: https:\/\/doi.org\/10.1016\/j.beem.2019.04.007","DOI":"10.1016\/j.beem.2019.04.007"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Rousseau-Merck MF, Misrahi M, Atger M, et al. Localization of the human luteinizing hormone\/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21. Cytogenet Genome Res. 1990;54(1-2):77-79. doi: https:\/\/doi.org\/10.1159\/000132962","DOI":"10.1159\/000132962"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Shenker A, Laue L, Kosugi S, et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993;365(6447):652-654. doi: https:\/\/doi.org\/10.1038\/365652a0","DOI":"10.1038\/365652a0"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Weinstein LS, Shenker A, Gejman PV., et al. Activating Mutations of the Stimulatory G Protein in the McCune\u2013Albright Syndrome. N Engl J Med. 1991;325(24):1688-1695. doi: https:\/\/doi.org\/10.1056\/NEJM199112123252403","DOI":"10.1056\/NEJM199112123252403"},{"key":"ref15","unstructured":"Svoboda P, et al. Biochemistry of transmembrane signaling mediated by trimeric G proteins. Physiol. Res. 2004;53(1):141-152."},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis. 2008;3(1):12. doi: https:\/\/doi.org\/10.1186\/1750-1172-3-12","DOI":"10.1186\/1750-1172-3-12"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Collins MT, Singer FR, Eugster E. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis. 2012;7(S1):S4. doi: https:\/\/doi.org\/10.1186\/1750-1172-7-S1-S4","DOI":"10.1186\/1750-1172-7-S1-S4"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Coutant R, Lumbroso S, Rey R, et al. Macroorchidism due to Autonomous Hyperfunction of Sertoli Cells and G s \u03b1 Gene Mutation: An Unusual Expression of McCune-Albright Syndrome in a Prepubertal Boy. J Clin Endocrinol Metab. 2001;86(4):1778-1781. doi: https:\/\/doi.org\/10.1210\/jcem.86.4.7391","DOI":"10.1210\/jc.86.4.1778"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Sinnecker G, Willig RP, Stahnke N, Braendle W. Precocious pseudopuberty associated with multiple ovarian follicular cysts and low plasma oestradiol concentrations. Eur J Pediatr. 1989;148(7):600-602. doi: https:\/\/doi.org\/10.1007\/BF00441508","DOI":"10.1007\/BF00441508"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Pienkowski C, Cartault A, Carfagna L, et al. Ovarian cysts in prepubertal girls. Endocr Dev. 2012;22:101-111. doi: https:\/\/doi.org\/10.1159\/000326627","DOI":"10.1159\/000326627"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Dehner LP. Gonadal and extragonadal germ cell neoplasia of childhood. Hum Pathol. 1983;14(6):493-511. doi: https:\/\/doi.org\/10.1016\/S0046-8177(83)80004-5","DOI":"10.1016\/S0046-8177(83)80004-5"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"McLachlan RI, O\u2019Donnell L, Meachem SJ, et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res. 2002;57:149-179. doi: https:\/\/doi.org\/10.1210\/rp.57.1.149","DOI":"10.1210\/rp.57.1.149"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kubo O, Yamasaki N, Kamijo Y, et al. Human chorionic gonadotropin produced by ectopic pinealoma in a girl with precocious puberty. J Neurosurg. 1977;47(1):101-105. doi: https:\/\/doi.org\/10.3171\/jns.1977.47.1.0101","DOI":"10.3171\/jns.1977.47.1.0101"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Kitanaka C, Matsutani M, Sora S, et al. Precocious puberty in a girl with an hCG-secreting suprasellar immature teratoma. J Neurosurg. 1994;81(4):601-604. doi: https:\/\/doi.org\/10.3171\/jns.1994.81.4.0601","DOI":"10.3171\/jns.1994.81.4.0601"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Anasti JN, Flack MR, Froehlich J, et al. A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab. 1995;80(1):276-279. doi: https:\/\/doi.org\/10.1210\/jcem.80.1.7829625","DOI":"10.1210\/jcem.80.1.7829625"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bezlepkina OB, Semicheva TV, Yarovaya IS. Van Wyk-Grumbach syndrome in children (Review of literature with descriptions of clinical cases). Problems of Endocrinology. 1994;40(4):35-38. (In Russ.). doi: https:\/\/doi.org\/10.14341\/probl12143","DOI":"10.14341\/probl12143"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wyk JJ Van, Grumbach MM. Syndrome of precocious menstruation and galactorrhea in juvenile hypothyroidism: an example of hormonal overlap in pituitary feedback. J Pediatr. 1960;57(3):416-435. doi: https:\/\/doi.org\/10.1016\/S0022-3476(60)80250-8","DOI":"10.1016\/S0022-3476(60)80250-8"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Fuqua JS. Treatment and outcomes of precocious puberty: an update. J Clin Endocrinol Metab. 2013;98(6):2198-2207. doi: https:\/\/doi.org\/10.1210\/jc.2013-1024","DOI":"10.1210\/jc.2013-1024"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"de Vries L, Guz-Mark A, Lazar L, et al. Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr. 2010;156(3):466-471. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2009.09.071","DOI":"10.1016\/j.jpeds.2009.09.071"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Novello L, Speiser PW. Premature Adrenarche. Pediatr Ann. 2018;47(1):e7-e11. doi: https:\/\/doi.org\/10.3928\/19382359-20171214-04","DOI":"10.3928\/19382359-20171214-04"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Teilmann G. Prevalence and Incidence of Precocious Pubertal Development in Denmark: An Epidemiologic Study Based on National Registries. Pediatrics. 2005;116(6):1323-1328. doi: https:\/\/doi.org\/10.1542\/peds.2005-0012","DOI":"10.1542\/peds.2005-0012"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Jung H, Ojeda SR. Pathogenesis of precocious puberty in hypothalamic hamartoma. Hormone Research. 2002;57(2):31-34. doi: https:\/\/doi.org\/10.1159\/000058097","DOI":"10.1159\/000058097"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Valdueza JM, Cristante L, Dammann O, et al. Hypothalamic Hamartomas. Neurosurgery. 1994;34(6):949-958. doi: https:\/\/doi.org\/10.1227\/00006123-199406000-00001","DOI":"10.1097\/00006123-199406000-00001"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Gjikopulli A, Kollcaku L, Grimci L, et al. P32 \u2013 2702: Hypothalamic hamartoma, gelastic epilepsy and precocious puberty. Eur J Paediatr Neurol. 2015;19:S103. doi: https:\/\/doi.org\/10.1016\/S1090-3798(15)30345-7","DOI":"10.1016\/S1090-3798(15)30345-7"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Stephen M, Zage P, Waguespack S. Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations. Int J Pediatr Endocrinol. 2011;2011(1):184502. doi: https:\/\/doi.org\/10.1155\/2011\/184502","DOI":"10.1155\/2011\/184502"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Wood LD, No\u00eb M, Hackeng W, et al. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch. 2017;470(4):391-400. doi: https:\/\/doi.org\/10.1007\/s00428-017-2086-2","DOI":"10.1007\/s00428-017-2086-2"},{"key":"ref37","unstructured":"Imel EA, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev PER. 2007;4(4):434-439."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Foster CM, Ross JL, Shawker T, et al. Absence of Pubertal Gonadotropin Secretion in Girls with McCune-Albright Syndrome. J Clin Endocrinol Metab. 1984;58(6):1161-1165. doi: https:\/\/doi.org\/10.1210\/jcem-58-6-1161","DOI":"10.1210\/jcem-58-6-1161"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Rivarola M, Belgorosky A, Mendilaharzu H, Vidal G. Precocious puberty in children with tumours of the suprasellar and pineal areas: Organic central precocious puberty. Acta Paediatr. 2007;90(7):751-756. doi: https:\/\/doi.org\/10.1111\/j.1651-2227.2001.tb02800.x","DOI":"10.1111\/j.1651-2227.2001.tb02800.x"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Mills JL. Premature Thelarche. Am J Dis Child. 1981;135(8):743. doi: https:\/\/doi.org\/10.1001\/archpedi.1981.02130320057019","DOI":"10.1001\/archpedi.1981.02130320057019"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"DeSalvo DJ, Mehra R, Vaidyanathan P, Kaplowitz PB. In children with premature adrenarche, bone age advancement by 2 or more years is common and generally benign. J Pediatr Endocrinol Metab. 2013;26(3-4):215-221. doi: https:\/\/doi.org\/10.1515\/jpem-2012-0283","DOI":"10.1515\/jpem-2012-0283"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Van Winter JT, Noller KL, Zimmerman D, Melton LJ. Natural history of premature thelarche in Olmsted County, Minnesota, 1940 to 1984. J Pediatr. 1990;116(2):278-280. doi: https:\/\/doi.org\/10.1016\/S0022-3476(05)82891-4","DOI":"10.1016\/S0022-3476(05)82891-4"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"de Vries L, Horev G, Schwartz M, Phillip M. Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur J Endocrinol. 2006;154(6):891-898. doi: https:\/\/doi.org\/10.1530\/eje.1.02151","DOI":"10.1530\/eje.1.02151"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Millar DM, Blake JM, Stringer DA, et al. Prepubertal Ovarian Cyst Formation: 5 Years\u2019 Experience. J Diagnostic Med Sonogr. 1993;9(3):168-168. doi: https:\/\/doi.org\/10.1177\/875647939300900331","DOI":"10.1177\/875647939300900331"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"de Sousa G, Wunsch R, Andler W. Precocious pseudopuberty due to autonomous ovarian cysts: A report of ten cases and long-term follow-up. Hormones. 2008;7(2):170-174. doi: https:\/\/doi.org\/10.1007\/BF03401509","DOI":"10.1007\/BF03401509"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Papanikolaou A, Michala L. Autonomous Ovarian Cysts in Prepubertal Girls. How Aggressive Should We Be? A Review of the Literature. J Pediatr Adolesc Gynecol. 2015;28(5):292-296. doi: https:\/\/doi.org\/10.1016\/j.jpag.2015.05.004","DOI":"10.1016\/j.jpag.2015.05.004"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Papadimitriou A, Beri D, Tsialla A, et al. Early growth acceleration in girls with idiopathic precocious puberty. J Pediatr. 2006;149(1):43-46. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2006.02.005","DOI":"10.1016\/j.jpeds.2006.02.005"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Fontoura M, Brauner R, Prevot C, Rappaport R. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child. 1989;64(8):1170-1176. doi: https:\/\/doi.org\/10.1136\/adc.64.8.1170","DOI":"10.1136\/adc.64.8.1170"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Ladjouze A, Soskin S, Garel C, et al. GH deficiency with central precocious puberty: A new rare disorder associated with a developmental defect of the hypothalamic-pituitary area. Eur J Endocrinol. 2007;156(4):463-469. doi: https:\/\/doi.org\/10.1530\/EJE-06-0688","DOI":"10.1530\/EJE-06-0688"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Burke AB, Collins MT, Boyce AM. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis. 2017;23(6):697-708. doi: https:\/\/doi.org\/10.1111\/odi.12563","DOI":"10.1111\/odi.12563"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Robinson C, Collins MT, Boyce AM. Fibrous Dysplasia\/McCune-Albright Syndrome: Clinical and Translational Perspectives. Curr Osteoporos Rep. 2016;14(5):178-186. doi: https:\/\/doi.org\/10.1007\/s11914-016-0317-0","DOI":"10.1007\/s11914-016-0317-0"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Kim I-S, Kim ER, Nam HJ, et al. Activating Mutation of GS\u03b1 in McCune-Albright Syndrome Causes Skin Pigmentation by Tyrosinase Gene Activation on Affected Melanocytes. Horm Res Paediatr. 1999;52(5):235-240. doi: https:\/\/doi.org\/10.1159\/000023467","DOI":"10.1159\/000023467"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Cisternino M, Arrigo T, Pasquino AM, et al. Etiology and Age Incidence of Precocious Puberty in Girls: A Multicentric Study. J Pediatr Endocrinol Metab. 2000;13(1):695-701. doi: https:\/\/doi.org\/10.1515\/JPEM.2000.13.S1.695","DOI":"10.1515\/JPEM.2000.13.S1.695"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in the Pattern of Pubertal Changes in Boys. Arch Dis Child. 1970;45(239):13-23. doi: https:\/\/doi.org\/10.1136\/adc.45.239.13","DOI":"10.1136\/adc.45.239.13"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291-303. doi: https:\/\/doi.org\/10.1136\/adc.44.235.291","DOI":"10.1136\/adc.44.235.291"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Neely EK, Hintz RL, Wilson DM, et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr. 1995;127(1):40-46. doi: https:\/\/doi.org\/10.1016\/S0022-3476(95)70254-7","DOI":"10.1016\/S0022-3476(95)70254-7"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Neely EK, Wilson DM, Lee PA, et al. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr. 1995;127(1):47-52. doi: https:\/\/doi.org\/10.1016\/S0022-3476(95)70255-5","DOI":"10.1016\/S0022-3476(95)70255-5"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Houk CP, Kunselman AR, Lee PA. Adequacy of a Single Unstimulated Luteinizing Hormone Level to Diagnose Central Precocious Puberty in Girls. Pediatrics. 2009;123(6):e1059-e1063. doi: https:\/\/doi.org\/10.1542\/peds.2008-1180","DOI":"10.1542\/peds.2008-1180"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Resende EAMR, Lara BHJ, Reis JD, et al. Assessment of Basal and Gonadotropin-Releasing Hormone-Stimulated Gonadotropins by Immunochemiluminometric and Immunofluorometric Assays in Normal Children. J Clin Endocrinol Metab. 2007;92(4):1424-1429. doi: https:\/\/doi.org\/10.1210\/jc.2006-1569","DOI":"10.1210\/jc.2006-1569"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Bay K, Andersson A-M, Skakkebaek NE. Estradiol levels in prepubertal boys and girls - analytical challenges. Int J Androl. 2004;27(5):266-273. doi: https:\/\/doi.org\/10.1111\/j.1365-2605.2004.00487.x","DOI":"10.1111\/j.1365-2605.2004.00487.x"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Harrington J, Palmert MR, Hamilton J. Use of local data to enhance uptake of published recommendations: an example from the diagnostic evaluation of precocious puberty. Arch Dis Child. 2014;99(1):15-20. doi: https:\/\/doi.org\/10.1136\/archdischild-2013-304414","DOI":"10.1136\/archdischild-2013-304414"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Lee D-M, Chung I-H. Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty. Ann Pediatr Endocrinol Metab. 2019;24(1):27-33. doi: https:\/\/doi.org\/10.6065\/apem.2019.24.1.27","DOI":"10.6065\/apem.2019.24.1.27"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91(6):357-372. doi: https:\/\/doi.org\/10.1159\/000501336","DOI":"10.1159\/000501336"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Kuiri-H\u00e4nninen T, Sankilampi U, Dunkel L. Activation of the Hypothalamic-Pituitary-Gonadal Axis in Infancy: Minipuberty. Horm Res Paediatr. 2014;82(2):73-80. doi: https:\/\/doi.org\/10.1159\/000362414","DOI":"10.1159\/000362414"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Bizzarri C, Spadoni GL, Bottaro G, et al. The Response to Gonadotropin Releasing Hormone (GnRH) Stimulation Test Does Not Predict the Progression to True Precocious Puberty in Girls With Onset of Premature Thelarche in the First Three Years of Life. J Clin Endocrinol Metab. 2014;99(2):433-439. doi: https:\/\/doi.org\/10.1210\/jc.2013-3292","DOI":"10.1210\/jc.2013-3292"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Pescovitz OH, Hench KD, Barnes KM, et al. Premature Thelarche and Central Precocious Puberty: The Relationship Between Clinical Presentation and the Gonadotropin Response to Luteinizing Hormone-Releasing Hormone. J Clin Endocrinol Metab. 1988;67(3):474-479. doi: https:\/\/doi.org\/10.1210\/jcem-67-3-474","DOI":"10.1210\/jcem-67-3-474"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Oerter KE, Uriarte MM, Rose SR, et al. Gonadotropin Secretory Dynamics During Puberty in Normal Girls and Boys. J Clin Endocrinol Metab. 1990;71(5):1251-1258. doi: https:\/\/doi.org\/10.1210\/jcem-71-5-1251","DOI":"10.1210\/jcem-71-5-1251"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Neely EK, Hintz RL, Wilson DM, et al. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr. 1995;127(1):40-46. doi: https:\/\/doi.org\/10.1016\/S0022-3476(95)70254-7","DOI":"10.1016\/S0022-3476(95)70254-7"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Brito VN. Diagnostic Value of Fluorometric Assays in the Evaluation of Precocious Puberty. J Clin Endocrinol Metab. 1999;84(10):3539-3544. doi: https:\/\/doi.org\/10.1210\/jc.84.10.3539","DOI":"10.1210\/jc.84.10.3539"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Brito VN, Latronico AC, Arnhold IJP, Mendonca BB. A Single Luteinizing Hormone Determination 2 Hours after Depot Leuprolide Is Useful for Therapy Monitoring of Gonadotropin-Dependent Precocious Puberty in Girls. J Clin Endocrinol Metab. 2004;89(9):4338-4342. doi: https:\/\/doi.org\/10.1210\/jc.2003-031537","DOI":"10.1210\/jc.2003-031537"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Pasternak Y, Friger M, Loewenthal N, et al. The utility of basal serum LH in prediction of central precocious puberty in girls. Eur J Endocrinol. 2012;166(2):295-299. doi: https:\/\/doi.org\/10.1530\/EJE-11-0720","DOI":"10.1530\/EJE-11-0720"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Sathasivam A, Garibaldi L, Shapiro S, et al. Original article: Leuprolide stimulation testing for the evaluation of early female sexual maturation. Clin Endocrinol (Oxf). 2010;73(3):375-381. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03796.x","DOI":"10.1111\/j.1365-2265.2010.03796.x"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Lee DS, Ryoo NY, Lee SH, et al. Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls? Ann Pediatr Endocrinol Metab. 2013;18(4):196. doi: https:\/\/doi.org\/10.6065\/apem.2013.18.4.196","DOI":"10.6065\/apem.2013.18.4.196"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Freire AV, Escobar ME, Gryngarten MG, et al. High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls. Clin Endocrinol (Oxf). 2013;78(3):398-404. doi: https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04517.x","DOI":"10.1111\/j.1365-2265.2012.04517.x"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Eckert KL, Wilson DM, Bachrach LK, et al. A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics. 1996;97:517-519.","DOI":"10.1542\/peds.97.4.517"},{"key":"ref76","unstructured":"Roger M, Lahlou N, Chaussain JL. Gonadotropin-releasing hormone testing in pediatrics. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents. Heidelberg, Germany: Johann Ambrosius Barth; 1996. P. 346-369."},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Wilson DA, Hofman PL, Miles HL, et al. Evaluation of the buserelin stimulation test in diagnosing gonadotropin deficiency in males with delayed puberty. J Pediatr. 2006;148(1):89-94. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2005.08.045","DOI":"10.1016\/j.jpeds.2005.08.045"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Khadilkar V, Khadilkar A, Prasad H, et al. Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders. Indian J Endocrinol Metab. 2012;16(3):400. doi: https:\/\/doi.org\/10.4103\/2230-8210.95682","DOI":"10.4103\/2230-8210.95682"},{"key":"ref79","unstructured":"Bolmasova AV. Optimizatsiya rostovogo prognoza u detei s gonadotropinzavisimymi formami prezhdevremennogo polovogo razvitiya opukholevogo i neopukholevogo geneza. [dissertation] Moscow; 2012. (In Russ.)."},{"key":"ref80","unstructured":"Chudecka-G\u0142az A, Rzepka-G\u00f3rska I, Kosmowska B, G\u0142az C. The levels of selected hormones in serum and ovarian cyst fluid in girls and young women. Ginekol Pol. 1999;70(5):236-241."},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Padilla SL. Androgen-producing tumors in children and adolescents. Adolesc Pediatr Gynecol. 1989;2(3):135-142. doi: https:\/\/doi.org\/10.1016\/S0932-8610(89)80003-9","DOI":"10.1016\/S0932-8610(89)80003-9"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Englund AT. Pediatric Germ Cell and Human Chorionic Gonadotropin \u2014 Producing Tumors. Am J Dis Child. 1991;145(11):1294. doi: https:\/\/doi.org\/10.1001\/archpedi.1991.02160110086026","DOI":"10.1001\/archpedi.1991.02160110086026"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Livadas S, Dracopoulou M, Dastamani A, et al. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Clin Endocrinol (Oxf). 2015;82(4):543-549. doi: https:\/\/doi.org\/10.1111\/cen.12543","DOI":"10.1111\/cen.12543"},{"key":"ref84","unstructured":"Razavi Z., RastgooHaghi A. Precocious Puberty Associated with an Adrenal Tumor: A case report. Iran J Ped Hematol Oncol. 2016;l6(2):136-141"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Goyal A, Malhotra R, Khadgawat R. Precocious pseudopuberty due to virilising adrenocortical carcinoma progressing to central precocious puberty after surgery. BMJ Case Rep. 2019;12(3):e229476. doi: https:\/\/doi.org\/10.1136\/bcr-2019-229476","DOI":"10.1136\/bcr-2019-229476"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Kafi SE, Alagha E, Shazly MA, Al-Agha A. Pseudo-precocious Puberty Associated with an Adrenocortical Tumor in a Young Child. Cureus. 2019;11(12):e6440. doi: https:\/\/doi.org\/10.7759\/cureus.6440","DOI":"10.7759\/cureus.6440"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Armengaud J-B, Charkaluk M-L, Trivin C, et al. Precocious Pubarche: Distinguishing Late-Onset Congenital Adrenal Hyperplasia from Premature Adrenarche. J Clin Endocrinol Metab. 2009;94(8):2835-2840. doi: https:\/\/doi.org\/10.1210\/jc.2009-0314","DOI":"10.1210\/jc.2009-0314"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Comite F, Schiebinger RJ, Albertson BD, et al. Isosexual Precocious Pseudopuberty Secondary to a Feminizing Adrenal Tumor. J Clin Endocrinol Metab. 1984;58(3):435-440. doi: https:\/\/doi.org\/10.1210\/jcem-58-3-435","DOI":"10.1210\/jcem-58-3-435"},{"key":"ref89","unstructured":"Tanner JM, Whitehouse RH, Marshall WA, et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method). New York: Academic Press$ 1975."},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Vejvoda M, Grant DB. Discordant bone maturation of the hand in children with precocious puberty and congenital adrenal hyperplasia. Acta Paediatr. 1981;70(6):903-905. doi: https:\/\/doi.org\/10.1111\/j.1651-2227.1981.tb06248.x","DOI":"10.1111\/j.1651-2227.1981.tb06248.x"},{"key":"ref91","unstructured":"Zhukovskii MA, Bukhman AI. Sroki okosteneniya skeleta kisti i distal\u2019nogo otdela predplech\u2019ya u detei i podrostkov g. Moskvy In: Detskaya endokrinologiya: Rukovodstvo dlya vrachei. Moscow: Meditsina; 1995. P. 40. (In Russ.)."},{"key":"ref92","unstructured":"Greulich W, Pyle S. Radiographic Atlas of Skeletal Development of the Hand and Wrist. Stanford, Calif: Stanford University Press; 1999."},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Bull RK, Edwards PD, Kemp PM, et al. Bone age assessment: a large scale comparison of the Greulich and Pyle, and Tanner and Whitehouse (TW2) methods. Arch Dis Child. 1999;81(2):172-173. doi: https:\/\/doi.org\/10.1136\/adc.81.2.172","DOI":"10.1136\/adc.81.2.172"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Fahmy JL, Kaminsky CK, Kaufman F, et al. The radiological approach to precocious puberty. Br J Radiol. 2000;73(869):560-567. doi: https:\/\/doi.org\/10.1259\/bjr.73.869.10884758","DOI":"10.1259\/bjr.73.869.10884758"},{"key":"ref95","unstructured":"Martin DD, Stahl K, Schweizer R, et al. Validation of BoneXpert in children with precocious puberty. Horm Res 2008;70(1):73."},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Breen MA, Tsai A, Stamm A, Kleinman PK. Bone age assessment practices in infants and older children among Society for Pediatric Radiology members. Pediatr Radiol. 2016;46(9):1269-1274. doi: https:\/\/doi.org\/10.1007\/s00247-016-3618-7","DOI":"10.1007\/s00247-016-3618-7"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Xu Y-Q, Li G-M, Li Y. Advanced bone age as an indicator facilitates the diagnosis of precocious puberty. J Pediatr (Rio J). 2018;94(1):69-75. doi: https:\/\/doi.org\/10.1016\/j.jped.2017.03.010","DOI":"10.1016\/j.jped.2017.03.010"},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Martin DD, Wit JM, Hochberg Z, et al. The Use of Bone Age in Clinical Practice \u2013 Part 2. Horm Res Paediatr. 2011;76(1):10-16. doi: https:\/\/doi.org\/10.1159\/000329374","DOI":"10.1159\/000329374"},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Mogensen SS, Aksglaede L, Mouritsen A, et al. Pathological and Incidental Findings on Brain MRI in a Single-Center Study of 229 Consecutive Girls with Early or Precocious Puberty. PLoS One. 2012;7(1):e29829. doi: https:\/\/doi.org\/10.1371\/journal.pone.0029829","DOI":"10.1371\/journal.pone.0029829"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"Lee J, Kim J, Yang A, et al. Etiological trends in male central precocious puberty. Ann Pediatr Endocrinol Metab. 2018;23(2):75-80. doi: https:\/\/doi.org\/10.6065\/apem.2018.23.2.75","DOI":"10.6065\/apem.2018.23.2.75"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Kaplowitz PB. Do 6-8 year old girls with central precocious puberty need routine brain imaging? Int J Pediatr Endocrinol. 2016;2016(1):9. doi: https:\/\/doi.org\/10.1186\/s13633-016-0027-5","DOI":"10.1186\/s13633-016-0027-5"},{"key":"ref102","doi-asserted-by":"crossref","unstructured":"Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. Am J Surg Pathol. 1985;9(3):177-192. doi: https:\/\/doi.org\/10.1097\/00000478-198503000-00002","DOI":"10.1097\/00000478-198503000-00002"},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Cecchetto G, Alaggio R, Bisogno G, et al. Sex cord-stromal tumors of the testis in children. A clinicopathologic report from the Italian TREP project. J Pediatr Surg. 2010;45(9):1868-1873. doi: https:\/\/doi.org\/10.1016\/j.jpedsurg.2010.02.120","DOI":"10.1016\/j.jpedsurg.2010.02.120"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Wendt S, Shelso J, Wright K, Furman W. Neoplastic causes of abnormal puberty. Pediatr Blood Cancer. 2014;61(4):664-671. doi: https:\/\/doi.org\/10.1002\/pbc.24825","DOI":"10.1002\/pbc.24825"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Alagha E, Kafi SE, Shazly MA, Al-Agha A. Precocious Puberty Associated with Testicular Hormone-secreting Leydig Cell Tumor. Cureus. December 2019;11(12):e6441. doi: https:\/\/doi.org\/10.7759\/cureus.6441","DOI":"10.7759\/cureus.6441"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Haber HP, Wollmann HA, Ranke MB. Pelvic ultrasonography: Early differentiation between isolated premature thelarche and central precocious puberty. Eur J Pediatr. 1995;154(3):182-186. doi: https:\/\/doi.org\/10.1007\/BF01954267","DOI":"10.1007\/BF01954267"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Sathasivam A, Rosenberg HK, Shapiro S, et al. Pelvic Ultrasonography in the Evaluation of Central Precocious Puberty: Comparison with Leuprolide Stimulation Test. J Pediatr. 2011;159(3):490-495. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2011.02.032","DOI":"10.1016\/j.jpeds.2011.02.032"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Badouraki M, Christoforidis A, Economou I, et al. Evaluation of pelvic ultrasonography in the diagnosis and differentiation of various forms of sexual precocity in girls. Ultrasound Obstet Gynecol. 2008;32(6):819-827. doi: https:\/\/doi.org\/10.1002\/uog.6148","DOI":"10.1002\/uog.6148"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Kang E, Cho JH, Choi J-H, Yoo H-W. Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty. Ann Pediatr Endocrinol Metab. 2016;21(3):136. doi: https:\/\/doi.org\/10.6065\/apem.2016.21.3.136","DOI":"10.6065\/apem.2016.21.3.136"},{"key":"ref110","doi-asserted-by":"crossref","unstructured":"Schneider DT, Terenziani M, Cecchetto G. et al., editors. Gonadal and extragonadal germ cell tumors, sex cord stromal and rare gonadal tumors. In: Rare Tumors in Children and Adolescents. Germany: Springer Berlin Heidelberg; 2102. P. 327-402.","DOI":"10.1007\/978-3-642-04197-6_39"},{"key":"ref111","doi-asserted-by":"crossref","unstructured":"Parida L. Nonurological malignancies in children. J Indian Assoc Pediatr Surg. 2014;19:31-37. doi: https:\/\/doi.org\/10.4103\/0971-9261.125960","DOI":"10.4103\/0971-9261.125960"},{"key":"ref112","doi-asserted-by":"crossref","unstructured":"Lin X, Wu D, Zheng N, et al. Gonadal germ cell tumors in children. Medicine (Baltimore). 2017;96(26):e7386. doi: https:\/\/doi.org\/10.1097\/MD.0000000000007386","DOI":"10.1097\/MD.0000000000007386"},{"key":"ref113","doi-asserted-by":"crossref","unstructured":"Javaid MK, Boyce A, Appelman-Dijkstra N, et al. Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium. Orphanet J Rare Dis. 2019;14(1):139. doi: https:\/\/doi.org\/10.1186\/s13023-019-1102-9","DOI":"10.1186\/s13023-019-1102-9"},{"key":"ref114","doi-asserted-by":"crossref","unstructured":"Mulder RL, Kremer LCM, Santen HM van, et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review. Cancer Treat Rev. 2009;35(7):616-632. doi: https:\/\/doi.org\/10.1016\/j.ctrv.2009.06.004","DOI":"10.1016\/j.ctrv.2009.06.004"},{"key":"ref115","doi-asserted-by":"crossref","unstructured":"van Iersel L, Li Z, Srivastava DK, et al. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes. J Clin Endocrinol Metab. 2019;104(12):6101-6115. doi: https:\/\/doi.org\/10.1210\/jc.2019-00834","DOI":"10.1210\/jc.2019-00834"},{"key":"ref116","doi-asserted-by":"crossref","unstructured":"Costin G, Kaufman F. Hypopituitarism and precocious puberty (pp). Pediatr Res. 1984;18(1):166A-166A. doi: https:\/\/doi.org\/10.1203\/00006450-198404001-00437","DOI":"10.1203\/00006450-198404001-00437"},{"key":"ref117","doi-asserted-by":"crossref","unstructured":"Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary. 2009;12(1):40-50. doi: https:\/\/doi.org\/10.1007\/s11102-008-0088-4","DOI":"10.1007\/s11102-008-0088-4"},{"key":"ref118","doi-asserted-by":"crossref","unstructured":"Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab. 2009;5(2):88-99. doi: https:\/\/doi.org\/10.1038\/ncpendmet1051","DOI":"10.1038\/ncpendmet1051"},{"key":"ref119","doi-asserted-by":"crossref","unstructured":"Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91(6):357-372. doi: https:\/\/doi.org\/10.1159\/000501336","DOI":"10.1159\/000501336"},{"key":"ref120","unstructured":"Federal Law of Russian Federation \u2116403 \u043ef 26.04.2012 (Ed. 20.11.2018) \u00abO poryadke vedeniya Federal\u2019nogo registra lits, stradayushchikh zhizneugrozhayushchimi i khronicheskimi progressiruyushchimi redkimi (orfannymi) zabolevaniyami, privodyashchimi k sokrashcheniyu prodolzhitel\u2019nosti zhizni grazhdan ili ikh invalidnosti, i ego regional\u2019nogo segmenta\u00bb. (In Russ.)."},{"key":"ref121","doi-asserted-by":"crossref","unstructured":"Lazar L, Padoa A, Phillip M. Growth Pattern and Final Height after Cessation of Gonadotropin-Suppressive Therapy in Girls with Central Sexual Precocity. J Clin Endocrinol Metab. 2007;92(9):3483-3489. doi: https:\/\/doi.org\/10.1210\/jc.2007-0321","DOI":"10.1210\/jc.2007-0321"},{"key":"ref122","doi-asserted-by":"crossref","unstructured":"Parker KL, Baens-Bailon RG, Lee PA. Depot Leuprolide Acetate Dosage for Sexual Precocity*. J Clin Endocrinol Metab. 1991;73(1):50-52. doi: https:\/\/doi.org\/10.1210\/jcem-73-1-50","DOI":"10.1210\/jcem-73-1-50"},{"key":"ref123","doi-asserted-by":"crossref","unstructured":"Partsch, E von B\u00fcren, M Bra C-J. Efficacy of the subcutaneous reformulated triptorelin depot in children with central precocious puberty. Acta Paediatr. 1998;87(12):1240-1244. doi: https:\/\/doi.org\/10.1080\/080352598750030906","DOI":"10.1111\/j.1651-2227.1998.tb00944.x"},{"key":"ref124","doi-asserted-by":"crossref","unstructured":"Tat\u00f2 L, Savage MO, Antoniazzi F, et al. Optimal Therapy of Pubertal Disorders in Precocious\/Early Puberty. J Pediatr Endocrinol Metab. 2001;14(2):985-995. doi: https:\/\/doi.org\/10.1515\/jpem-2001-s211","DOI":"10.1515\/jpem-2001-s211"},{"key":"ref125","doi-asserted-by":"crossref","unstructured":"Antoniazzi F, Zamboni G. Central Precocious Puberty. Pediatr Drugs. 2004;6(4):211-231. doi: https:\/\/doi.org\/10.2165\/00148581-200406040-00002","DOI":"10.2165\/00148581-200406040-00002"},{"key":"ref126","unstructured":"Yilmaz GC, Kara C, Bitkin EC, Aydin HM. Comparison of Triptorelin Versus Leuprolide in Treatment of Girls with Central Precocious Puberty. In European Society for Paediatric Endocrinology; [Internet] 2016 [cited 2019 Dec 9]. Available from: http:\/\/abstracts.eurospe.org\/hrp\/0086\/hrp0086p2-p778."},{"key":"ref127","doi-asserted-by":"crossref","unstructured":"Lahlou N, Carel J-C, Chaussain J-L, Roger M. Pharmacokinetics and Pharmacodynamics of GnRH Agonists: Clinical Implications in Pediatrics. J Pediatr Endocrinol Metab. 2000;13(1):723-737. doi: https:\/\/doi.org\/10.1515\/JPEM.2000.13.S1.723","DOI":"10.1515\/JPEM.2000.13.S1.723"},{"key":"ref128","doi-asserted-by":"crossref","unstructured":"Boepple PA, Mansfield MJ, Wierman ME, et al. Use of a Potent, Long Acting Agonist of Gonadotropin-Releasing Hormone in the Treatment of Precocious Puberty*. Endocr Rev. 1986;7(1):24-33. doi: https:\/\/doi.org\/10.1210\/edrv-7-1-24","DOI":"10.1210\/edrv-7-1-24"},{"key":"ref129","doi-asserted-by":"crossref","unstructured":"Cook JS, Doty KL, Conn PM, Hansen JR. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab. 1992;74(5):1206-1209. doi: https:\/\/doi.org\/10.1210\/jcem.74.5.1569169","DOI":"10.1210\/jcem.74.5.1569169"},{"key":"ref130","doi-asserted-by":"crossref","unstructured":"Carel J-C, Lahlou N, Guazzarotti L, et al. Treatment of central precocious puberty with depot leuprorelin. Eur J Endocrinol. 1995;132(6):699-704. doi: https:\/\/doi.org\/10.1530\/eje.0.1320699","DOI":"10.1530\/eje.0.1320699"},{"key":"ref131","doi-asserted-by":"crossref","unstructured":"Lawson ML, Cohen N. A Single Sample Subcutaneous Luteinizing Hormone (LH)-Releasing Hormone (LHRH) Stimulation Test for Monitoring LH Suppression in Children with Central Precocious Puberty Receiving LHRH Agonists 1. J Clin Endocrinol Metab. 1999;84(12):4536-4540. doi: https:\/\/doi.org\/10.1210\/jcem.84.12.6181","DOI":"10.1210\/jcem.84.12.6181"},{"key":"ref132","doi-asserted-by":"crossref","unstructured":"Brito VN, Latronico AC, Arnhold IJP, Mendonca BB. A Single Luteinizing Hormone Determination 2 Hours after Depot Leuprolide Is Useful for Therapy Monitoring of Gonadotropin-Dependent Precocious Puberty in Girls. J Clin Endocrinol Metab. 2004;89(9):4338-4342. doi: https:\/\/doi.org\/10.1210\/jc.2003-031537","DOI":"10.1210\/jc.2003-031537"},{"key":"ref133","doi-asserted-by":"crossref","unstructured":"Carel J-C, Blumberg J, Seymour C, et al. Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. Eur J Endocrinol. 2006;154(1):119-124. doi: https:\/\/doi.org\/10.1530\/eje.1.02056","DOI":"10.1530\/eje.1.02056"},{"key":"ref134","doi-asserted-by":"crossref","unstructured":"Badaru A, Wilson DM, Bachrach LK, et al. Sequential Comparisons of One-Month and Three-Month Depot Leuprolide Regimens in Central Precocious Puberty. J Clin Endocrinol Metab. 2006;91(5):1862-1867. doi: https:\/\/doi.org\/10.1210\/jc.2005-1500","DOI":"10.1210\/jc.2005-1500"},{"key":"ref135","doi-asserted-by":"crossref","unstructured":"Latronico AC, Brito VN, Carel J-C. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016;4(3):265-274. doi: https:\/\/doi.org\/10.1016\/S2213-8587(15)00380-0","DOI":"10.1016\/S2213-8587(15)00380-0"},{"key":"ref136","doi-asserted-by":"crossref","unstructured":"Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91:1-16. doi: https:\/\/doi.org\/10.1159\/000501336","DOI":"10.1159\/000501336"},{"key":"ref137","unstructured":"Federal\u2019nye klinicheskie rekomendatsii (protokoly) po vedeniyu detei F32 s endokrinnymi zabolevaniyami. Ed by Dedova II, Peterkovoi VA. Moscow: Praktika; 2014. P. 277\u2013294. (In Russ.)."},{"key":"ref138","unstructured":"Prikaz Ministerstva zdravookhraneniya i sotsial\u2019nogo razvitiya Rossiiskoi Federatsii ot 5.05.2012. \u2116502n \u00abOb utverzhdenii poryadka sozdaniya i deyatel\u2019nosti vrachebnoi komissii meditsinskoi organizatsii\u00bb. (In Russ.)."},{"key":"ref139","doi-asserted-by":"crossref","unstructured":"Mieszczak J, Lowe ES, Plourde P, Eugster EA. The Aromatase Inhibitor Anastrozole Is Ineffective in the Treatment of Precocious Puberty in Girls with McCune-Albright Syndrome. J Clin Endocrinol Metab. 2008;93(7):2751-2754. doi: https:\/\/doi.org\/10.1210\/jc.2007-2090","DOI":"10.1210\/jc.2007-2090"},{"key":"ref140","doi-asserted-by":"crossref","unstructured":"Estrada A, Boyce AM, Brillante BA, et al. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune\u2013Albright syndrome. Eur J Endocrinol. 2016;175(5):477-483. doi: https:\/\/doi.org\/10.1530\/EJE-16-0526","DOI":"10.1530\/EJE-16-0526"},{"key":"ref141","doi-asserted-by":"crossref","unstructured":"Feuillan P, Calis K, Hill S, et al. Letrozole Treatment of Precocious Puberty in Girls with the McCune-Albright Syndrome: A Pilot Study. J Clin Endocrinol Metab. 2007;92(6):2100-2106. doi: https:\/\/doi.org\/10.1210\/jc.2006-2350","DOI":"10.1210\/jc.2006-2350"},{"key":"ref142","doi-asserted-by":"crossref","unstructured":"Eugster EA, Rubin SD, Reiter EO, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr. 2003;143(1):60-66. doi: https:\/\/doi.org\/10.1016\/S0022-3476(03)00128-8","DOI":"10.1016\/S0022-3476(03)00128-8"},{"key":"ref143","doi-asserted-by":"crossref","unstructured":"de G. Buff Passone C, Kuperman H, Cabral de Menezes-Filho H, et al. Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up. Horm Res Paediatr. 2015;84(3):184-189. doi: https:\/\/doi.org\/10.1159\/000435881","DOI":"10.1159\/000435881"},{"key":"ref144","doi-asserted-by":"crossref","unstructured":"Sims EK, Garnett S, Guzman F, et al. Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol. 2012;2012(1):26. doi: https:\/\/doi.org\/10.1186\/1687-9856-2012-26","DOI":"10.1186\/1687-9856-2012-26"},{"key":"ref145","doi-asserted-by":"crossref","unstructured":"Kreher NC, Pescovitz OH, Delameter P, et al. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr. 2006;149(3):416-420. doi: https:\/\/doi.org\/10.1016\/j.jpeds.2006.04.027","DOI":"10.1016\/j.jpeds.2006.04.027"},{"key":"ref146","doi-asserted-by":"crossref","unstructured":"Reiter EO, Mauras N, McCormick K, et al. Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT). J Pediatr Endocrinol Metab. 2010;23(10). doi: https:\/\/doi.org\/10.1515\/jpem.2010.161","DOI":"10.1515\/jpem.2010.161"},{"key":"ref147","doi-asserted-by":"crossref","unstructured":"Tessaris D, Matarazzo P, Mussa A, et al. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Endocr J. 2012;59(2):111-117. doi: https:\/\/doi.org\/10.1507\/endocrj.EJ11-0214","DOI":"10.1507\/endocrj.EJ11-0214"},{"key":"ref148","doi-asserted-by":"crossref","unstructured":"G\u00fcven A, Nurcan Cebeci A, Hancili S. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty. Hormones. 2015;14(2):265. doi: https:\/\/doi.org\/10.14310\/horm.2002.1555","DOI":"10.14310\/horm.2002.1555"},{"key":"ref149","doi-asserted-by":"crossref","unstructured":"Pescovitz OH, Comite F, Cassorla F, et al. True Precocious Puberty Complicating Congenital Adrenal Hyperplasia: Treatment with a Luteinizing Hormone-Releasing Hormone Analog*. J Clin Endocrinol Metab. 1984;58(5):857-861. doi: https:\/\/doi.org\/10.1210\/jcem-58-5-857","DOI":"10.1210\/jcem-58-5-857"},{"key":"ref150","doi-asserted-by":"crossref","unstructured":"Brito VN, Spinola-Castro AM, Kochi C, et al. Central precocious puberty: Revisiting the diagnosis and therapeutic management. Arch Endocrinol Metab. 2016;60(2):163-172. doi: https:\/\/doi.org\/10.1590\/2359-3997000000144","DOI":"10.1590\/2359-3997000000144"},{"key":"ref151","doi-asserted-by":"crossref","unstructured":"Breen JL, Maxson WS. Ovarian tumors in children and adolescents. Clinical Obstetrics Gynecol. 1977;20(3):607e23.","DOI":"10.1097\/00003081-197709000-00010"},{"key":"ref152","doi-asserted-by":"crossref","unstructured":"Mayer SK, Oligny LL, Deal C, et al. Childhood adrenocortical tumors: Case series and reevaluation of prognosis - A 24-year experience. J Pediatr Surg. 1997;32(6):911. doi: https:\/\/doi.org\/10.1016\/S0022-3468(97)90649-7","DOI":"10.1016\/S0022-3468(97)90649-7"},{"key":"ref153","doi-asserted-by":"crossref","unstructured":"Cheville JC, Sebo TJ, Lager DJ, et al. Leydig cell tumor of the testis: A clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol. 1998;22(11):1361. doi: https:\/\/doi.org\/10.1097\/00000478-199811000-00006","DOI":"10.1097\/00000478-199811000-00006"},{"key":"ref154","doi-asserted-by":"crossref","unstructured":"Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838-845. doi: https:\/\/doi.org\/10.1200\/JCO.2004.08.085","DOI":"10.1200\/JCO.2004.08.085"},{"key":"ref155","doi-asserted-by":"crossref","unstructured":"Murray MJ, Bartels U, Nishikawa R, et al. Consensus on the management of intracranial germ-cell tumours. Lancet Oncol. 2015;16(9):e470-e477. doi: https:\/\/doi.org\/10.1016\/S1470-2045(15)00244-2","DOI":"10.1016\/S1470-2045(15)00244-2"},{"key":"ref156","unstructured":"Klinicheskie rekomendatsii \u00abEkstrakranial\u2019nye germinogenno-kletochnye opukholi u detei\u00bb razrabotannye Natsional\u2019nym obshchestvom detskikh gematologov, onkologov. 2020. (In Russ.). \u0414\u043e\u0441\u0442\u0443\u043f\u043d\u043e \u043f\u043e \u0441\u0441\u044b\u043b\u043a\u0435: https:\/\/cr.minzdrav.gov.ru\/schema\/69_1#doc_b"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/12821\/9983","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T01:59:27Z","timestamp":1673747967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/12821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":156,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,11,12]]}},"URL":"https:\/\/doi.org\/10.14341\/probl12821","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"value":"2308-1430","type":"electronic"},{"value":"0375-9660","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}